news

Equinox Pharma Holding Limited (Equinox), alongside other investors, further increases its stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.

Rameda Reports its FY21 Results

Rameda Reports its 3Q21 Results

Rameda Reports its 2Q21 Results

Equinox Pharma Holding Limited (Equinox) increases its stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. acquires a sizeable molecule in a fast-growing therapeutic area

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.’s Chief Executive Officer, Dr. Amr Morsy, recognized among the top 100 Arabian CEOs of 2020

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E., (together with its consolidated subsidiaries, “Rameda”) with ticker name RMDA.CA on EGX, a leading Egyptian pharmaceutical company, announces today that its Chief Executive Officer (CEO), Dr. Amr Morsy, has been named as one of...

Rameda notified of Anviziram, Remdesivir-Rameda vial prices by Egyptian Drug Authority, on track to market first Remdesivir-Rameda production in September 2020

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents SAE (Rameda), RMDA.CA on the EGX, a leading Egyptian pharmaceutical company, announced today that it has been notified by the Egyptian Drug Authority of the public price for its product “Anviziram.” Anviziram, which contains the active...

Rameda commences manufacture of “Anviziram” Tablets the Generic Equivalent of Japanese antiviral Avigan for treatment of Covid-19 patients and receives approval from Egyptian Drug Authority to manufacture Remedsivir

Rameda, a leading Egyptian pharmaceutical company, announced today that it has commenced the manufacture of Anviziram. Anviziram contains the active pharmaceutical ingredient Favipiravir, which is the generic form of the antiviral sold under the brand name Avigan in Japan. Rameda has also secured approval from...

Rameda launches initiative for the complementary dispensary and home delivery of medication at no cost, underlining its dedication to ensuring the healthcare and safety among Egypt’s most immune-compromised patient populations amid the COVID-19 pandemic

Rameda, is pleased to announces today the launch of Rameda’s SPP (“Save Yourself, Stay Home, Protect your Family, Protect your Community”) project, aimed at reducing elderly and patients with special needs’ risk of exposure to COVID-19 through the electronic dispensary and home delivery of cardiovascular,...